NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Neurode

Neurode

Private
SydneyHealthcare & Life Scienceshttps://neurodelabs.com/

Last Round

Grant

Sep 21, 2025

Total Funding Raised

$5.55M

Momentum

Top 10%

of companies Caplight tracks

Company Overview

Neurode is a healthtech company that develops a wearable headset and accompanying mobile application designed to monitor and treat ADHD symptoms through non-invasive electrical brain stimulation.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Mental Health, Health IoT, D2C Brands

Business Model

B2C

Customer Profile

Hardware + Subscription

AI Layer

Application

Keywords

neurotechnologywearable devicebrain-computer interfaceBCIneuro-monitoringdigital healthfunctional near-infrared spectroscopyfNIRSADHD managementclosed-loop stimulationbiohackingmental health techcognitive healthDTC hardwarebrain-sensing

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Neurode Comparables

Compare Neurode with similar companies based on industry and business-model similarity.

Neurode comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Mendi Innovations
82%
Myndlift
78%
Flow Neuroscience
77%

Neurode Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
GrantSep 21, 2025
Pre SeedSep 11, 2024

Neurode Investors

Notable investors and investment history

Neurode investors
InvestorRounds
Khosla VenturesPre Seed
SOSVAccelerator, Pre Seed
HAXAccelerator, Pre Seed
Stoic Venture CapitalPre Seed

Market signals

Structured signals derived from secondary market and firmographic data.

  • May 19, 2026

    Monthly visitors increased 87% MoM, reaching 14.8K.

  • May 18, 2026

    Open roles increased to 8, representing 53% of headcount.

Neurode Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Neurode Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Neurode's valuation, stock price, and market status.

Firmographic Details

HeadquartersSydney
Employee Range14
Year Founded2021
Last FundingSep 21, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.